ProPhase Labs Inc (PRPH) concluded trading on Wednesday at a closing price of $0.44, with 4.28 million shares of worth about $1.88 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -83.64% during that period and on Wednesday the price saw a loss of about -9.82%. Currently the company’s common shares owned by public are about 29.87M shares, out of which, 25.49M shares are available for trading.
Stock saw a price change of -22.79% in past 5 days and over the past one month there was a price change of -1.12%. Year-to-date (YTD), PRPH shares are showing a performance of -41.87% which decreased to -91.13% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.22 but also hit the highest price of $7.48 during that period. The average intraday trading volume for ProPhase Labs Inc shares is 9.23 million. The stock is currently trading 17.64% above its 20-day simple moving average (SMA20), while that difference is down -17.41% for SMA50 and it goes to -80.71% lower than SMA200.
ProPhase Labs Inc (NASDAQ: PRPH) currently have 29.87M outstanding shares and institutions hold larger chunk of about 8.10% of that.
The stock has a current market capitalization of $13.15M and its 3Y-monthly beta is at -0.56. It has posted earnings per share of -$1.50 in the same period. It has Quick Ratio of 1.33 while making debt-to-equity ratio of 0.78. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for PRPH, volatility over the week remained 24.64% while standing at 27.45% over the month.
Stock’s fiscal year EPS is expected to drop by -29.59% while it is estimated to increase by 55.91% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by H.C. Wainwright on December 20, 2021 offering a Buy rating for the stock and assigned a target price of $12 to it.
